Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. Trial N/A Recruiting March 15, 2026
Terazosin And Metabolic Energetics in Parkinson's Disease Trial Phase 2 Not yet recruiting March 15, 2026
Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease Trial Phase 2 Completed March 15, 2026
Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease Trial N/A Recruiting March 15, 2026
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease Trial Phase 2 Completed March 12, 2026
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease Trial Phase 1 Completed March 12, 2026
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism Trial Phase 2 Not yet recruiting March 12, 2026
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) Trial Phase 1 Active, not recruiting March 12, 2026
Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease Trial Phase 4 Terminated March 12, 2026
Tackling Anxiety-related Freezing of Gait in People With Parkinson's Disease Trial N/A Completed March 11, 2026
Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism Trial Phase 2 Completed March 11, 2026
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study Trial N/A Recruiting March 10, 2026